Research Article

A Retrospective Observational Study on Disease Characteristics and Treatment Patterns of Giant Cell Tumor of the Bone in China

Table 2

Disease characteristics (FAS and UMNAS).

ItemDescriptionFAS ()UMNAS ()
Primary diagnosis ()Last disease recurrence ()Primary diagnosis ()Last disease recurrence ()

Target lesion anatomic site, (%)Extremities
Upper limbs116 (17.4)40 (20.0)24 (13.9)12 (15.0)
Lower limbs462 (69.2)149 (74.5)78 (45.1)59 (73.8)
Axial bone
Spine55 (8.2)7 (3.5)55 (31.8)7 (8.8)
Pelvis34 (5.1)4 (2.0)15 (8.7)2 (2.5)

Metastasis, (%)Yes12 (1.8)16 (8.0)12 (6.9)16 (20.0)
No656 (98.2)184 (92.0)161 (93.1)64 (80.0)

Spine or sacrum GCTB or metastatic GCTB, (%)Yes66 (9.9)23 (11.5)66 (38.2)23 (28.8)
No602 (90.1)177 (88.5)107 (61.9)57 (71.3)

Pathological diagnosis, (%)BGCT668 (100.0)200 (100.0)173 (100.0)80 (100.0)

Secondary malignancy diagnosisMGCT1 (0.50)
Malignant mesenchymal tumor1 (0.50)1 (12.5)
Undifferentiated small cell sarcoma1 (0.50)1 (12.5)

BGCT = benign giant cell tumor; FAS = full analysis set; GCTB = giant cell tumor of the bone; MGCT = malignant giant cell tumor; UMNAS = unmet medical needs analysis set.